Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases.
Placental site trophoblastic tumour (PSTT) is a neoplastic proliferation of the implantation intermediate trophoblast. Although clinicopathological studies are not uncommon in case reports or small series, molecular and genetic studies are quite limited. Four archived cases of PSTT were successfully analysed by comparative genomic hybridization (CGH) in this study. Regional chromosomal gains were observed in two cases. One case showed chromosomal gains in the regions of 19p13.2, 21q11-21 and 22q12. The second case demonstrated a single regional chromosomal gain involving 21q21. No chromosomal loss is observed. The remaining two cases showed a balanced CGH profile without detectable chromosomal gain or loss. In summary, although chromosomal alterations detectable by CGH are not common, rare chromosomal gains do occur in PSTT. The recurrent chromosomal gain involving chromosomal 21q observed in two of our cases deserves additional studies to ascertain whether it carries any pathobiological significance.
Hui
Pei
P
Department of Pathology, Weil Medical College of Cornell University, USA. pei.hui@yale.edu
Riba
Ali
A
Pejovic
Tanja
T
Johnson
Tulin
T
Baergen
Rebecca N
RN
Ward
David
D
D005260:Female; D006801:Humans; D009693:Nucleic Acid Hybridization; D011247:Pregnancy; D018245:Trophoblastic Tumor, Placental Site / Q000235:genetics* / Q000473:pathology*; D014594:Uterine Neoplasms / Q000235:genetics* / Q000473:pathology*